Funding
Keil University spin-out SciEngines GmbH has won venture capital backing to finance the development of a supercomputing platform for data-intensive life sciences applications.
This is based on a massively parallel Field Programmable Gate Arrays-based architecture that improves the performance of existing applications and algorithms, whilst also having lower power requirements.
The company says software developers implementing their applications on the SciEngines platform will not have to change their software, and it will help them to adapt and port custom algorithms to the architecture.
Claas H Nieraad, managing director of the New Commercial Room GmbH, the Hamburg-based VC firm said, “The technical approach, combined with an early market successes in the field of cryptanalysis, has convinced us [to invest].” The firm joins the public fund High-Tech Gründerfonds in backing SciEngines.
“The team at SciEngines has shown they are capable of developing high performance computers with their existing product line for cryptanalysis. The bioinformatics market seems to fit perfectly to the upcoming products of SciEngines,” said Klaus Lehmann, Senior Investment manager at High-Tech Gründerfonds.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.